MEDIZINISCHE HOCHSCHULE HANNOVER
- Country
- Germany
- Type
- Beneficiary
- Website
- www.mh-hannover.de
- Calls awarded
- 2
- Grants received
- 120
Funding record
- 120 grants on record
- €58,114,473.76 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- European Research Council
- Horizon Europe Framework Programme
- Horizon 2020 Framework Programme
49 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- KATHOLIEKE UNIVERSITEIT LEUVEN
- ACADEMISCH ZIEKENHUIS LEIDEN
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- MEDIZINISCHE UNIVERSITAET WIEN
- FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
- UNIVERSITAIR MEDISCH CENTRUM UTRECHT
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
Calls from this organisation
- MHH - Rahmenvereinbarung zum bedarfsorientierten Austausch von Endoskopie-Systemen inklusive Servicevereinbarung in der Gastroenterologie der Medizinischen Hochschule (MHH)
- MHH - Parkdeck P01 und Hubschrauberlandeplatz (HDL) - Objektplanung Ingenieurbauwerke
Grants received
- Molecular Imaging to Guide Repair and Advance Therapy: Targeting the inflammation-fibrosis axis in ischemic heart disease and remote organs
- Elucidating the role of RNA-binding proteins in Kaposi’s sarcoma-associated herpesvirus infected cells during latency-reactivation switches
- Moving cell-based immunotherapies to fight bacterial lung infections into the clinics
- Next-generation models and genetic therapies for rare neuromuscular diseases
- International Study for Treatment of Childhood Relapsed ALL 2020
- Master Framework and Pragmatic Clinical Trial for Relapse or Refractory Acute Myeloid Leukemia
- Custom-Made Designer Macrophages to Revolutionize the Safety of Parenteral Drugs
- Rehabilitation and Diagnosis of Hearing Loss based on Electric Acoustic Interaction
- Circular RNAs to reverse pathological remodelling of the injured heart
- HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart
- Pre-clinical development of a lentiviral gene therapy to treat hearing and balance loss in Usher 1B patients
- Targeting cardiac fibrosis with next generation RNA therapeutics
- Deciphering cellular and viral determinants of lytic HSV-1 infection, latency and reactivation
- heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data
- Noncoding RNA MEG3 inhibitor for Heart Failure Treatment
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Source: Datenservice Öffentlicher Einkauf (Germany — procurement notices).
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.